James Crowe Jr.
May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
Apr. 8, 2015—Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.
Feb. 26, 2015—Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
Jan. 29, 2015—During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care.
Dec. 1, 2014—In the latest VUCast: Learn why overweight women lose in the workplace -- especially when it comes to pay; see breakthrough weapons in the fight against infectious diseases; and hear music legend Sheryl Crow speak about her craft. Watch now!
Oct. 31, 2014—Ambassadors from 26 nations visited Vanderbilt Oct. 31 and heard from Chancellor Nicholas S. Zeppos and two researchers about their work.
Oct. 28, 2014—Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.
Oct. 21, 2014— Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization announced this week. With more than 1,900 active members and foreign associates, the IOM...
Sep. 24, 2014—Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.
Sep. 18, 2014—Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.
May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...
Apr. 7, 2014—World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the Caribbean and South America—and is predicted to soon cause outbreaks in the United States. For many years the virus has remained primarily...